1. Home
  2. SONN vs OESX Comparison

SONN vs OESX Comparison

Compare SONN & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • OESX
  • Stock Information
  • Founded
  • SONN N/A
  • OESX 1996
  • Country
  • SONN United States
  • OESX United States
  • Employees
  • SONN N/A
  • OESX N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • OESX Building Products
  • Sector
  • SONN Health Care
  • OESX Consumer Discretionary
  • Exchange
  • SONN Nasdaq
  • OESX Nasdaq
  • Market Cap
  • SONN 21.4M
  • OESX 21.6M
  • IPO Year
  • SONN N/A
  • OESX 2007
  • Fundamental
  • Price
  • SONN $5.90
  • OESX $8.91
  • Analyst Decision
  • SONN Strong Buy
  • OESX Strong Buy
  • Analyst Count
  • SONN 1
  • OESX 2
  • Target Price
  • SONN $20.00
  • OESX $17.50
  • AVG Volume (30 Days)
  • SONN 825.4K
  • OESX 21.4K
  • Earning Date
  • SONN 08-13-2025
  • OESX 11-05-2025
  • Dividend Yield
  • SONN N/A
  • OESX N/A
  • EPS Growth
  • SONN N/A
  • OESX N/A
  • EPS
  • SONN N/A
  • OESX N/A
  • Revenue
  • SONN $1,000,000.00
  • OESX $79,389,000.00
  • Revenue This Year
  • SONN $5,376.22
  • OESX $6.63
  • Revenue Next Year
  • SONN N/A
  • OESX $13.51
  • P/E Ratio
  • SONN N/A
  • OESX N/A
  • Revenue Growth
  • SONN 1689.52
  • OESX N/A
  • 52 Week Low
  • SONN $1.08
  • OESX $5.50
  • 52 Week High
  • SONN $19.30
  • OESX $10.35
  • Technical
  • Relative Strength Index (RSI)
  • SONN 74.18
  • OESX 76.97
  • Support Level
  • SONN $2.71
  • OESX $7.18
  • Resistance Level
  • SONN $4.35
  • OESX $9.09
  • Average True Range (ATR)
  • SONN 0.58
  • OESX 0.54
  • MACD
  • SONN 0.22
  • OESX 0.20
  • Stochastic Oscillator
  • SONN 80.96
  • OESX 93.75

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.

Share on Social Networks: